secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0001641172-25-013433
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD appoints Michael Lawless as CFO, succeeding Craig Shore
-----------------------------------------------------------------

- Michael Lawless appointed CFO effective on/before June 30, 2025; succeeds Craig Shore who served ~15 years.
- Base salary of $375,000 annually, plus performance bonus up to 50% of base salary.
- Inducement grant: 212,000 stock options and 465,000 restricted shares, vesting over 3 years under NASDAQ Rule 5635(c)(4).
- Employment agreement has 3-year initial term with automatic renewal; severance includes 6 months base salary (non-CIC) or 12 months (CIC).
- Lawless previously CFO of Lifeward (LFWD) and held senior finance roles at Azenta, PerkinElmer, and Momenta Pharmaceuticals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000164117225013433/0001641172-25-013433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000164117225013433/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer